文献速递慢性肾脏病遗传性与小管间质肾病

尿表皮生长因子与常染色体显性多囊肾病疾病严重程度及进展的关联

The association of urinary epidermal growth factors with ADPKD disease severity and progression.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

研究在301例常染色体显性多囊肾病(ADPKD)患者和72例年龄性别匹配的活体肾捐献者中检测24小时尿EGF与HB-EGF,发现ADPKD患者尿EGF排泄低于健康对照,且低尿EGF与更快的eGFR下降独立相关;单侧肾切除后尿EGF排泄下降46.4%。

要点

  • ADPKD患者尿EGF排泄低于健康对照,而尿HB-EGF两组无差异。
  • 尿EGF与基线eGFR正相关,低尿EGF与更快的GFR下降相关。
  • 单侧肾切除后尿EGF排泄下降46.4%,伴随eGFR和mGFR下降。

核心结论

  • 数据提示较低的尿EGF排泄可能是ADPKD患者肾功能下降的有价值的新型预测指标。

研究设计与样本

  • 研究测量了301例ADPKD患者和72例年龄性别匹配的活体肾捐献者24小时尿中的EGF和HB-EGF。
  • 中位随访2.5年,用混合模型分析尿EGFR配体排泄与ADPKD患者eGFR年变化及身高调整总肾体积的关联。
  • 用免疫组化研究了ADPKD肾组织中三种密切相关的EGFR家族受体的表达。
  • 评估了减少肾质量(肾捐献后)对尿EGF的影响,以探讨尿EGF是否反映剩余健康肾组织量。

主要发现

  • 基线时ADPKD患者尿HB-EGF与健康对照无差异(P = .6)。
  • ADPKD患者尿EGF排泄为18.6(11.8-27.8)μg/24 h,低于健康对照的51.0(34.9-65.4)μg/24 h(P < .001)。
  • 尿EGF与基线eGFR正相关(R = 0.54,P < .001),低EGF与更快的GFR下降强烈相关(β = 1.96,P < .001),即使调整ADPKD严重程度标志物后仍如此;HB-EGF则无此关联。
  • 肾囊肿中观察到EGFR表达,而非其他EGFR相关受体;非ADPKD肾组织中无表达。
  • 单侧肾切除后尿EGF排泄下降46.4(-63.3至-17.6)%,eGFR下降35.2 ± 7.2%,mGFR下降36.8 ± 6.9%,最大mGFR(多巴胺诱导高灌注后测量)下降46.1 ± 7.8%(均P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The epidermal growth factor receptor (EGFR) pathway is involved in kidney tissue repair and growth. Preclinical interventional data and scarce human data have suggested a role for this pathway in the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), while other data have suggested that its activation is causally linked to repair of damaged kidney tissue. We hypothesize that urinary EGFR ligands, as a reflection of EGFR activity, are associated with kidney function decline in ADPKD in the context of tissue repair following injury, and as the disease progresses as a sign of insufficient repair. METHODS: In the present study, we measured the EGFR ligands, EGF and heparin binding-EGF (HB-EGF), in 24-h urine samples of 301 ADPKD patients and 72 age- and sex-matched living kidney donors to dissect the role of the EGFR pathway in ADPKD. During a median follow-up of 2.5 years, the association of urinary EGFR ligand excretion with annual change in estimated glomerular filtration rate (eGFR) and height-adjusted total kidney volume in ADPKD patients was analyzed using mixed-models methods, and the expression of three closely related EGFR family receptors in ADPKD kidney tissue was investigated by immunohistochemistry. Additionally, the effect of reducing renal mass (after kidney donation), was assessed to investigate whether urinary EGF matches this reduction and thus reflects the amount of remaining healthy kidney tissue. RESULTS: At baseline, urinary HB-EGF did not differ between ADPKD patients and healthy controls (P = .6), whereas a lower urinary EGF excretion was observed in ADPKD patients [18.6 (11.8-27.8)] compared with healthy controls [51.0 (34.9-65.4) μg/24 h, P < .001]. Urinary EGF was positively associated with baseline eGFR (R = 0.54, P < .001) and a lower EGF was strongly associated with a more rapid GFR decline, even when adjusted for ADPKD severity markers (β = 1.96, P < .001), whereas HB-EGF was not. Expression of the EGFR, but not other EGFR-related receptors, was observed in renal cysts but was absent in non-ADPKD kidney tissue. Finally, unilateral nephrectomy resulted in a decrease of 46.4 (-63.3 to -17.6) % in urinary EGF excretion, alongside a decrease of 35.2 ± 7.2% in eGFR and 36.8 ± 6.9% in measured GFR (mGFR), whereas maximal mGFR (measured after dopamine induced hyperperfusion) decreased by 46.1 ± 7.8% (all P < .001). CONCLUSIONS: Our data suggest that lower urinary EGF excretion may be a valuable novel predictor for kidney function decline in patients with ADPKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Harskamp LR, Perez-Gomez MV, Heida JE, et al. The association of urinary epidermal growth factors with ADPKD disease severity and progression. Nephrol Dial Transplant. 2023. PMID: 36914219. doi:10.1093/ndt/gfad050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。